respectively'*°. However, this study did not include
a control arm, and most of the trials of favilavir were
based on a small sample size. For more reliable assess-
ment of the effectiveness of favilavir for treating
COVID-19, large-scale randomized controlled trials

should be conducted.

Lopinavir and ritonavir were reported to have
in vitro inhibitory activity against SARS-CoV and
MERS-CoV'"*"'**, Alone, the combination of lopinavir
